- 全部删除
您的购物车当前为空
CAY10566 是选择性的、口服具有活性的硬脂酰辅酶 A 去饱和酶 1 抑制剂,在小鼠和人酶测定中IC50分别为 4.5 和 26 nM。它具有显著的细胞活性,可阻断 HepG2 细胞中饱和长链脂肪酸-CoAs (LCFA-CoAs) 向单不饱和 LCFA-CoAs 的转化 。


为众多的药物研发团队赋能,
让新药发现更简单!
CAY10566 是选择性的、口服具有活性的硬脂酰辅酶 A 去饱和酶 1 抑制剂,在小鼠和人酶测定中IC50分别为 4.5 和 26 nM。它具有显著的细胞活性,可阻断 HepG2 细胞中饱和长链脂肪酸-CoAs (LCFA-CoAs) 向单不饱和 LCFA-CoAs 的转化 。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 472 | In stock | |
| 5 mg | ¥ 826 | In stock | |
| 10 mg | ¥ 1,150 | In stock | |
| 25 mg | ¥ 1,960 | In stock | |
| 50 mg | ¥ 3,150 | In stock | |
| 100 mg | ¥ 4,520 | In stock | |
| 200 mg | ¥ 6,350 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 693 | In stock |
CAY10566 相关产品
| 产品描述 | CAY10566 shows excellent cellular activity in blocking the conversion of saturated long-chain fatty acid-CoAs (LCFA-CoAs) to monounsaturated LCFA-CoAs in HepG2 cells (IC50=7.9 nM or 6.8 nM). CAY10566 is a potent, orally bioavailable and selective stearoyl-CoA desaturase1 (SCD1) inhibitor with IC50s of 4.5 and 26 nM in mouse and human enzymatic assays, respectively.. |
| 靶点活性 | SCD1 (human):26 nM (IC50), SCD1 (mouse):4.5 nM (IC50) |
| 体外活性 | CAY10566(0.0001-10 μM;24小时)浓度依赖性减少Swiss 3T3细胞增殖[3]。 |
| 体内活性 | 在明显肿瘤形成后,小鼠分别接受载体或SCD1抑制剂(口服CAY10566,每天两次,每次2.5 mg/kg)的治疗。SCD1抑制对Akt驱动的肿瘤影响大于Ras驱动的肿瘤。以治疗后第13或14天的平均肿瘤体积与未治疗肿瘤相比,分别为0.5±0.04和0.67±0.05(Ras与Akt比较,双尾t检验,P=0.01)[4]。 |
| 分子量 | 389.81 |
| 分子式 | C18H17ClFN5O2 |
| CAS No. | 944808-88-2 |
| Smiles | Cc1nnc(o1)-c1ccc(nn1)N1CCC(CC1)Oc1cc(F)ccc1Cl |
| 密度 | 1.369 g/cm3 (Predicted) |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 24 mg/mL (61.57 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (5.13 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容